Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck
Authors:
- Study of Digestive Health (SDH)S(Study of Digestive Health (SDH)
- Annika AntonssonAAAnnika Antonsson
- Matthew H. LawMLMatthew H. Law
- Rachel E. NealeRNRachel E. Neale
- David I. PryorDPDavid I. Pryor
- David C. WhitemanDWDavid C. Whiteman
- 20 April 2016
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 27 (6) , 809-815
Abstract
Purpose There is a growing association of human papillomavirus (HPV) with some cases of mucosal squamous cell carcinoma of the head and neck (HNSCC), particularly of the oropharynx. Persistent oral HPV infection is believed to increase the likelihood of malignancy, and it is possible that host genetic factors can determine susceptibility to persistent HPV infection. Polymorphisms in the two EV genes (EVER1 and EVER2, also known as transmembrane channel protein (TMC) 6 and 8) have been identified as strong candidate genes, since a small number of critical mutations in these genes have been shown to cause profound and florid skin HPV infections, and some of them have been linked to susceptibility to cervical cancer. Methods We sought to determine whether there was a difference in the frequency of single nucleotide polymorphisms (SNPs) in EVER1 (rs2613516, rs12449858) and EVER2 (rs7205422, rs12452890) between HNSCC patients with HPV-positive and HPV-negative tumors, and healthy controls. We used logistic regression to analyze SNPs in 219 patients with histologically confirmed primary SCC of the oropharynx, oral cavity, hypopharynx, or larynx, and 321 healthy controls. Results We did not find any associations with the EVER1/EVER2 SNPs and HPV status or being a HNSCC case or a control. Conclusions The present data do not provide evidence for a role of genetic variations in EVER1 or EVER2 for HPV status of mucosal HNSCC or between HNSCC patients and controls.Keywords
Funding Information
- National Health and Medical Research Council (APP1006480, APP1065293, APP1058522, APP1060183)
- Garnett Passe and Rodney Williams Memorial Foundation
- National Cancer Institute (R01CA136725)
This publication has 19 references indexed in Scilit:
- Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibilityInternational Journal of Cancer, 2011
- Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancersBritish Journal of Cancer, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimensPharmacogenetics and Genomics, 2010
- Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical CancerPLOS ONE, 2010
- Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: A case‐control studyInternational Journal of Cancer, 2008
- Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomavirusesJournal of Experimental Medicine, 2007
- NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteinsNucleic Acids Research, 2004
- Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformisNature Genetics, 2002
- Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformisJournal of the American Academy of Dermatology, 1990